Nutrastar Announces Full Year 2013 Results
Revenue Up 17.9% Year-Over-Year; Gross Margin at 77.8%
HARBIN, China, March 26, 2014 /PRNewswire-FirstCall/ -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages and organic and specialty foods, today announced its results for the year ended December 31, 2013.
Financial Highlights
- Net revenue was $43.35 million, an increase of 17.9% from full year 2012.
- Gross profit was $33.72 million, an increase of 20.4% from previous year, representing a gross margin of 77.8%.
- Net income was $22.17 million, an increase of $4.93 million from year 2012, representing a net margin of 51.1%.
- Basic and diluted EPS were $1.38 and $1.30, respectively, with 15.95 million basic shares and 17.09 million diluted shares outstanding.
Management Commentary
"We are pleased to report augmented sales in each of our consumer product categories for the full year 2013. Cordyceps product sales were up $5.94 million or 21.4% year-over-year. Functional health beverages containing Cordyceps and organic specialty foods, our ancillary consumer product categories, saw an 8.2% and 3.6% sales increase, respectively. As a whole, revenue was $43.35 million, up 17.9%, just short of our forecasted revenue of between $44 and $46 million due to a push out of the anticipated ramp up of our organic and specialty food business. As seen in past years, growing demand within China for our core consumer product Cordyceps was the primary driver of our overall increase in revenue.
As for our bottom line, we continue to operate at highly efficient and profitable levels, and see improvements in cost and operations. For the year ended December 31, 2013, gross profit and net income, as a percentage of revenue, increased to 77.8% and 51.1%, from 76.2% and 46.9%, respectively. Aiding in this improvement was the Q1 2013 completion of our multi-phase, multi-year production capacity expansion project. For the year 2013, we were at approximately 91 tons capacity and expect to hit the upper 90's by the end of 2014," Ms. Lianyun Han, CEO of Nutrastar, commented.
Ms. Han continued, "Right now, while we are in an excellent position to capitalize on numerous opportunities with the Chinese consumer product market, our focus remains steadfast on growing our core consumer product offerings. As the largest producer of commercially cultivated Cordyceps Militaris, we are keenly aware of market demand and are confident in our ability to stay on top of the competition particularly within China. As mentioned in our third quarter 2013 results, we are actively working towards expanding into the international market with our in-development Cordyceps capsules and tablets, designed to complement our current premium consumer product offering and cater to our everyday customer looking for an on-the-go health supplement similar to other vitamin-type supplements. This is a huge milestone we expect to achieve in 2015."
On the subject of the Company's financial position and growth ahead, Ms. Han added, "We closed the year with a cash balance of approximately $102.6 million. This cash balance was vouched and verified by our independent auditor, and is earmarked the Company's future organic and inorganic growth initiatives such as continued capacity expansion, brand and product development, marketing & advertising, any potential strategic and synergistic acquisitions. With the proper, intelligent allocation of funds, we will continue building greater market awareness for our premium Cordyceps consumer products in China and ease our way into the international market with Cordyceps in tablet and capsule form."
Nutrastar encourages any interested party to reach out to directly for more information on the Company and its innovative, premium consumer product portfolio.
Outlook for the Year Ending December 31, 2014
Based on management's current expectations, full year 2014 revenue should fall in the range of $47 million to $50 million, representing an approximate 8% to 15% top line increase year-over-year.
Request for Call with Management
Investors are invited to request a call with Nutrastar's management team. For those investors who are interested in speaking with management, please contact American Capital Ventures at +1-305-918-7000 to schedule.
For more information regarding Nutrastar's financial performance during the year ended December 31, 2013, please refer to the Annual Report on Form 10-K to be filed with the Securities and Exchange Commission on or about March 26, 2014.
About Nutrastar International Inc.
Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 330 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: [email protected]
Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts
Safe Harbor Statement
This news release contains "forward-looking statements" relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact:
Howard Gostfrand
American Capital Ventures
Tel: +1-305-918-7000
Email: [email protected]
NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES |
|||||
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME |
|||||
(AMOUNTS EXPRESSED IN US DOLLARS) |
|||||
Year Ended December 31, |
|||||
2013 |
2012 |
||||
REVENUE |
$ |
43,348,989 |
$ |
36,771,176 |
|
Cost of goods sold |
(9,633,349) |
(8,742,166) |
|||
GROSS PROFIT |
33,715,640 |
28,029,010 |
|||
Operating expenses: |
|||||
Selling expenses |
(1,848,488) |
(1,658,956) |
|||
General and administrative expenses |
(3,216,459) |
(3,102,070) |
|||
Gain on re-measurement of accrued staff fringe and social benefits |
934,855 |
- |
|||
Income from operations |
29,585,548 |
23,267,984 |
|||
Other income: |
|||||
Interest income |
324,145 |
255,918 |
|||
Foreign exchange differences |
64,653 |
5,610 |
|||
Change in fair value of warrants |
173 |
144,238 |
|||
Other income |
8,073 |
7,921 |
|||
Total other income |
397,044 |
413,687 |
|||
Income before income taxes |
29,982,592 |
23,681,671 |
|||
Provision for income taxes |
(7,812,222) |
(6,438,960) |
|||
NET INCOME |
$ |
22,170,370 |
$ |
17,242,711 |
|
Earnings per share |
|||||
Basic |
$ |
1.38 |
$ |
1.10 |
|
Diluted |
$ |
1.30 |
$ |
1.04 |
|
Weighted average number of shares outstanding |
|||||
Basic |
15,949,537 |
15,453,656 |
|||
Diluted |
17,089,460 |
16,600,053 |
NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES |
|||||
CONSOLIDATED BALANCE SHEETS |
|||||
(AMOUNTS EXPRESSED IN US DOLLARS) |
|||||
December 31, |
|||||
2013 |
2012 |
||||
ASSETS |
|||||
CURRENT ASSETS |
|||||
Cash and cash equivalents |
$ |
102,599,186 |
$ |
75,526,533 |
|
Accounts receivable |
56,922 |
81,497 |
|||
Inventories |
691,847 |
965,251 |
|||
Prepayments and other receivables |
1,300,012 |
1,321,726 |
|||
Total current assets |
104,647,967 |
77,895,007 |
|||
OTHER ASSETS |
|||||
Intangible assets, net |
1,107,737 |
1,552,022 |
|||
Property, plant and equipment, net |
15,481,249 |
15,991,060 |
|||
Total assets |
$ |
121,236,953 |
$ |
95,438,089 |
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||
CURRENT LIABILITIES |
|||||
Other payables and accruals |
$ |
1,167,957 |
$ |
1,481,198 |
|
Taxes payable |
2,879,172 |
2,981,136 |
|||
Due to a related party |
265,223 |
150,036 |
|||
Preferred stock dividend payable |
738,903 |
528,528 |
|||
Warrants liabilities |
- |
173 |
|||
Total current liabilities |
5,051,255 |
5,141,071 |
|||
Total liabilities |
5,051,255 |
5,141,071 |
|||
COMMITMENTS AND CONTINGENCIES |
|||||
STOCKHOLDERS' EQUITY |
|||||
Preferred Stock, $0.001 par value, 1,000,000 shares authorized, |
2,510,183 |
2,577,324 |
|||
Common stock, $0.001 par value, 190,000,000 shares authorized, |
16,422 |
15,908 |
|||
Additional paid-in capital |
19,934,551 |
19,029,586 |
|||
Statutory reserves |
4,983,935 |
4,960,023 |
|||
Treasury stock, at cost, 43,555 shares as of December 31, 2013 and 2012 |
(78,767) |
(78,767) |
|||
Retained earnings |
80,242,877 |
58,325,932 |
|||
Accumulated other comprehensive income |
8,576,497 |
5,467,012 |
|||
Total stockholders' equity |
116,185,698 |
90,297,018 |
|||
Total liabilities and stockholders' equity |
$ |
121,236,953 |
$ |
95,438,089 |
NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES |
|||||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||
(AMOUNTS EXPRESSED IN US DOLLARS) |
|||||
Year Ended December 31, |
|||||
2013 |
2012 |
||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|||||
Net income |
$ |
22,170,370 |
$ |
17,242,711 |
|
Adjustments to reconcile net income to cash provided by operating activities: |
|||||
Change in fair value of warrants |
(173) |
(144,238) |
|||
IR warrant and restricted stock expense |
17,804 |
45,000 |
|||
Depreciation and amortization |
1,473,496 |
1,235,468 |
|||
Loss on disposal of property and equipment |
- |
76,219 |
|||
Share-based compensation expense |
801,396 |
809,664 |
|||
(Increase) decrease in assets: |
|||||
Accounts receivable |
26,676 |
1,216 |
|||
Inventories |
298,548 |
(63,903) |
|||
Prepayments and other receivables |
61,626 |
(123,802) |
|||
Increase (decrease) in liabilities: |
|||||
Accounts payable |
- |
(6,327) |
|||
Other payables and accruals |
(351,591) |
412,785 |
|||
Taxes payable |
(191,162) |
387,399 |
|||
Net cash provided by operating activities |
24,306,990 |
19,872,192 |
|||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|||||
Purchase of property, plant and equipment |
- |
(315,257) |
|||
Refund of payments for building construction |
- |
1,267,327 |
|||
Net cash provided by investing activities |
- |
952,070 |
|||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|||||
Purchase of common stock |
- |
(69,214) |
|||
Decrease in restricted cash |
- |
4,170 |
|||
Advance from a related party |
46,173 |
64,829 |
|||
Net cash provided by (used in) financing activities |
46,173 |
(215) |
|||
Foreign currency translation adjustment |
2,719,490 |
146,157 |
|||
INCREASE IN CASH AND CASH EQUIVALENTS |
27,072,653 |
20,970,204 |
|||
CASH AND CASH EQUIVALENTS, at the beginning of the year |
75,526,533 |
54,556,329 |
|||
CASH AND CASH EQUIVALENTS, at the end of the year |
$ |
102,599,186 |
$ |
75,526,533 |
|
NON-CASH TRANSACTIONS |
|||||
Preferred stock and dividend converted into common stock |
$ |
86,279 |
$ |
995,587 |
|
Preferred stock dividend payable |
229,513 |
200,382 |
|||
Share-based payment to officers and directors under equity incentive plan |
801,396 |
809,664 |
|||
Share-based payment – IR warrants and restricted shares |
17,804 |
45,000 |
|||
SUPPLEMENTAL DISCLOSURE INFORMATION |
|||||
Income taxes paid |
$ |
7,683,689 |
$ |
6,179,713 |
SOURCE Nutrastar International Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article